INSIGHTS ON DRUG DEVELOPMENT
-
Managing Endotoxins - Detect, Prevent, Remove
Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.
-
NGS Identification Of Internal Tandem Duplications In FLT3
Accurately identifying genetic duplications in leukemia requires more than conventional sequencing. See how advanced enrichment and analysis approaches enable deeper insight into variant structure.
-
Studying The Spatial Architecture Of Glioblastoma
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
Expanding Opportunities For Inhaled Drug Delivery
Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners8/5/2026
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
API In Capsule Vs. The Lost Art Of Formulation Development11/5/2025
API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
Tablet Manufacturing Technologies For Solid Drug Formulation4/2/2025
Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.
-
Accelerated Yield Optimization Of Affinity Capture5/15/2026
High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.
-
Using AI-Analysis And High-Content Screening To Improve Data Capturing4/4/2025
Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.
DRUG DEVELOPMENT SOLUTIONS
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
The BioAccord™ LC-MS System with dedicated workflows for the Sartorius Ambr® 15 and small bioreactors enables process engineers to directly measure Product Quality Attributes (PQAs) and cell culture media.
-
Easily analyze a diverse array of RNA species, from 50-9,000 bases, and achieve high-resolution data with a purity & integrity kit.
-
Eurofins CDMO Alphora handles small molecule APIs and HPAPIs from IND-enabling through commercialization, with FDA and Health Canada-approved facilities scaling up to 125 kg per batch. Contact them to discuss your program.
-
OSDPredict™ uses artificial intelligence and machine learning to help sponsors proactively identify and address formulation challenges early — before they can disrupt downstream development.